Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial.

Notably, transplanted patients who received RQ-PCR MRD-negative autografts, regardless of whether obtained after the first or the second R-HD-ARA-C course, showed a trend towards PFS advantage, even if not statistically significant (median PFS 56 and 37 months for negative and positive LK MRD samples respectively, p = 0.128) (Fig. 4 ).

also in 53,322 other papers